The Methylation Connection: Impact of MTHFR C677T and A1298C Variants on Homocysteine, Folate, and B12 Profiles in Adolescent Cardiovascular Health

Priya Kalidhas 1, Kavitha Marudachalam 1 * , Thirunavukkarasu Jaishankar 2 * , Sarguru Datchanamurthi 3, Vairavan Pillai Subbammal Kalaiselvi 4
More Detail
1 Department of Biochemistry, Vinayaka Mission's Kirupananda Variyar Medical College and Hospitals, Vinayaka Mission's Research Foundation (Deemed to be University), Tamil Nadu, India
2 Department of Biochemistry, Karpagam Faculty of Medical Science and Research, Coimbatore, Tamil Nadu, India
3 Department of Biochemistry, Sri Lalithambigai Medical College, Dr. MGR Educational and Research Institute, Maduravoyal, Chennai, Tamil Nadu, India
4 Department of Biochemistry, Sree Balaji Medical College and Hospital, Bharath Institute of Higher Education and Research, Chennai, Tamil Nadu, India
* Corresponding Author
J CLIN MED KAZ, Volume 23, Issue 3, pp. 58-65. https://doi.org/10.23950/jcmk/18499
OPEN ACCESS 522 Views 161 Downloads
Download Full Text (PDF)
Author Contributions: Conceptualization, P.K.D and T.J; Methodology, K.M and P.K.D.; Formal Analysis, T.J; Investigation, K.M, and S.D.; Resources, S.D.; Data Curation, S.D.; Writing – Original Draft Preparation, T.J and K.V.S; Writing – Review & Editing, K.V.S., T.J., and K.M.; Supervision, S.D; Project Administration, P.K.D. All authors have read and agreed to the published version of the manuscript.

Data availability statement: The datasets generated during and/or analyzed during the current study are available from the corresponding author on reasonable request.

Patient Informed Consent Statement: All subjects gave their informed consent for inclusion before participating in the study.

Artificial Intelligence (AI) Disclosure Statement: The authors declare no AI Tools used for preparation of this work.

ABSTRACT

Background: Coronary heart disease (CHD) is a leading cause of death in South Asia. Genetic and metabolic factors play a significant role in the burden of CHD. Although associations between homocysteine, MTHFR polymorphisms, and CHD have been previously reported, the synergistic interaction of genetic variants with micronutrient deficiency and dyslipidemia in a South Asian cohort has not been adequately explored. The present study aims to elucidate these multivariate interactions to address this critical gap in knowledge.
Methods: This case-control investigation was conducted among clinically confirmed CHD patients and healthy controls recruited from adults aged 35–55 years at Sri Lalithambigai Medical College & Hospital, Chennai, India, from October 2025 to January 2026. Plasma homocysteine, folate, vitamin B12, and lipid profiles were determined using chemiluminescent and enzymatic assays. Genotyping of MTHFR C677T (rs1801133) and A1298C (rs1801131) polymorphisms was performed using PCR-RFLP analysis. Statistical analyses included Pearson correlation, multivariate logistic regression with interaction analysis, ROC curve analysis, and a composite risk scoring model.
Results: Plasma homocysteine levels were significantly elevated in CHD patients (37.69±2.86 µmol/L) compared to controls (18.41±4.02 µmol/L; p<0.001). Folate levels were significantly lower in CHD patients (8.37±4.24 ng/mL) versus controls (10.03±8.67 ng/mL; p<0.001). Both groups demonstrated vitamin B12 values below the conventional reference range (200–900 pg/mL), consistent with the high prevalence of B12 insufficiency in South Indian vegetarian-predominant populations; notably, CHD patients showed comparatively higher B12 levels (105.37±12.58 pg/mL vs. 80.32±15.67 pg/mL in controls; p<0.001), the interpretation of which is discussed. Risk genotypes for MTHFR C677T (CT+TT) and A1298C (AC+CC) were significantly more prevalent in CHD patients, with odds ratios of 2.4 (95% CI: 1.13–3.80) and 2.92 (95% CI: 1.34–10.44), respectively. The composite genetic-metabolic risk score achieved an AUC of 0.912, outperforming individual biomarkers.
Conclusions: Integrated evaluation of MTHFR polymorphisms, hyperhomocysteinemia, micronutrient deficiencies, and dyslipidemia shows promise for improving CHD risk stratification in South Asian populations. These findings are associative in nature and require prospective cohort validation before informing clinical application. Population-specific, genotype-guided nutritional intervention strategies warrant further investigation through randomised controlled trials.
 
Keywords: Hyperhomocysteinemia, MTHFR polymorphisms, coronary heart disease, South Asian population, precision cardiovascular medicine

CITATION

Kalidhas P, Marudachalam K, Jaishankar T, Datchanamurthi S, Kalaiselvi VPS. The Methylation Connection: Impact of MTHFR C677T and A1298C Variants on Homocysteine, Folate, and B12 Profiles in Adolescent Cardiovascular Health. J CLIN MED KAZ. 2026;23(3):58-65. https://doi.org/10.23950/jcmk/18499

REFERENCES

  • Di Cesare M, Perel P, Taylor S, Kabudula C, Bixby H, Gaziano TA, McGhie DV, Mwangi J, Pervan B, Narula J, Pineiro D, Pinto FJ. The Heart of the World. Global Heart. 2024;19(1):11. https://doi.org/10.5334/gh.1288
  • Libby P. Inflammation in atherosclerosis. Arterioscler Thromb Vasc Biol. 2012;32(9):2045–2051. https://doi.org/10.1161/ATVBAHA.108.179705
  • Falk E, Zhou J, Møller J. Homocysteine and atherothrombosis. Lipids. 2001;36 Suppl:S3–S11. https://doi.org/10.1007/s11745-001-0676-x
  • Prasad K. Atherogenic Effect of Homocysteine. Int J Angiol. 2024;33(4):262–270. https://doi.org/10.1055/s-0044-1788280
  • Humphrey LL, Fu К, Rogers K, Freeman M, Helfand M. Homocysteine level and coronary heart disease incidence. Mayo Clin Proc. 2008;83(11):1203–1212. https://doi.org/10.4065/83.11.1203
  • Mayfield JA, Davies MW, Dimster-Denk D, Pleskac N, McCarthy S, Boydston EA, Fink L, Lin XX, Narain AS, Meighan M, Rine J. Surrogate genetics and metabolic profiling. Genetics. 2012;190(4):1309–1323. https://doi.org/10.1534/genetics.111.137471
  • Ueland P, Hustad S, Schneede J, Refsum H, Vollset SE. Biological and clinical implications of MTHFR C677T. Trends Pharmacol Sci. 2001;22(4):195–201. https://doi.org/10.1016/s0165-6147(00)01675-8
  • Frosst P, Blom H.J, Milos R, Goyette P, Sheppard CA, Matthews RG, Boers GJH, den Heijer M, Kluijtmans LAJ, van den Heuve LP, Rozen R.. A candidate genetic risk factor for vascular disease. Nat Genet. 1995;10(1):111–113. https://doi.org/10.1038/ng0595-111
  • Weisberg I, Tran P, Christensen B, Sibani S, Rozen R. A second genetic polymorphism in MTHFR. Mol Genet Metab. 1998;64(3):169–172. https://doi.org/10.1006/mgme.1998.2714
  • Wilcken B, Bamforth F, Li Z, et al. Geographical and ethnic variation of the 677C>T allele of MTHFR. J Med Genet. 2003;40(8):619–625. https://doi.org/10.1136/jmg.40.8.619
  • Stover PJ, Durga J, Field MS. Folate nutrition and blood-brain barrier dysfunction. Curr Opin Biotechnol. 2017;44:146–152. https://doi.org/10.1016/j.copbio.2017.01.006
  • Refsum H, Ueland PM, Nygård O, Vollset SE. Homocysteine and cardiovascular disease. Annu Rev Med. 1998;49:31–62. https://doi.org/10.1146/annurev.med.49.1.31
  • Ganguly P, Alam SF. Role of homocysteine in the development of cardiovascular disease. Nutr J. 2015;14:6. https://doi.org/10.1186/1475-2891-14-6
  • Zhang C, Cai Y, Adachi MT, Oshiro S, Aso T, Kaufman RJ, Kitajima. Homocysteine induces programmed cell death in vascular endothelial cells. J Biol Chem. 2001;276(38):35867–35874. https://doi.org/10.1074/jbc.M100747200
  • Motti C, Gnasso A, Bernardini S, Massouda R, Pastorec A, Rampaa P, Federicia G, Cortesea C. Common mutation in MTHFR. Atherosclerosis. 1998;139(2):377–383. https://doi.org/10.1016/s0021-9150(98)00079-3
  • Farzamnia H, Varzandeh P, Almasi N, Arasteh M. Association between serum homocysteine and coronary artery disease. ARYA Atherosclerosis. 2011;7(2):63–67.
  • Lonn E, et al. Homocysteine lowering with folic acid and B vitamins (HOPE-2). N Engl J Med. 2006;354(15):1567–1577. https://doi.org/10.1056/NEJMoa060900
  • Zhang MJ, Hu ZH, Yin YW, Li BH, Liu Y, Liao SQ, Gao CY, Li JC, Zhang LL. Meta-analysis of MTHFR A1298C and stroke risk. Cerebrovasc Dis. 2014;38(6):425–432. https://doi.org/10.1159/000369122
  • Jakubowski H. Homocysteine is a protein amino acid in humans. J Biol Chem. 2002;277(34):30425–30428. https://doi.org/10.1074/jbc.C200267200
  • Clarke R, Bennett DA, Parish S, Verhoef P, Dötsch-Klerk M, Lathrop M, et al. (MTHFR Studies Collaborative Group). Homocysteine and coronary heart disease: meta-analysis of MTHFR case-control studies. PLoS Med. 2012;9(2):e1001177. https://doi.org/10.1371/journal.pmed.1001177
  • Lewis SJ, Ebrahim S, Davey Smith G. Meta-analysis of MTHFR 677C->T polymorphism and coronary heart disease: does totality of evidence support causal role for homocysteine and preventive potential of folate? BMJ. 2005;331(7524):1053. https://doi.org/10.1136/bmj.38611.658947.55